GOLDAN KEITH A. (Chief Financial Officer) sold 2.4% of their position (3.41K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $71.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/10/2026ACC: 0001193125-26-043813
Officer· Chief Financial Officer
Since Jun 2022
-3.41K
Net shares
Net seller
$71.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.41K
Price / share
$21.03
Trade value
$71.71K
% of position
2.4%
2/9/2026
143.84K→140.43K
Total
Net shares
−3.41K
Net value
-$71.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | S · Sale | −3.41K | $21.03 | $71.71K | 2.4% | 143.84K | 140.43K |
| Total | −3.41K | -$71.71K | ||||||
Derivative Transactions0
No derivative transactions reported